| Literature DB >> 24392307 |
Rajiv Kumar1, Houari Korideck2, Wilfred Ngwa2, Ross I Berbeco2, G Mike Makrigiorgos2, Srinivas Sridhar1.
Abstract
We report the design and fabrication of third generation ultrasmall PEGylated gold nanoparticles based platform (AuRad™) optimized for applications in radiation therapy. The AuRad™ nanoplatform has the following key features: (I) surface coating of hetero-bifunctional-PEG with amine, carboxyl, methoxy functional groups, which make this a versatile nanoplatform to conjugate various moieties like fluorophores, peptides, drugs, radiolabels; (II) size that is optimized for longer circulation, higher tumor uptake and modulated clearance; (III) high radiation enhancement. We have synthesized ultrasmall 2-3 nm gold nanoparticles, followed by attachment of hetero-bifunctional PEG and further conjugation of fluorophore AlexaFlour 647 for optical imaging, with a stability of more than 6 months. Confocal bioimaging with HeLa cells showed robust uptake of biocompatible nanoparticles in cells. Irradiation experiments X-rays showed greater than 2.8-fold cell kill enhancement as demonstrated by clonogenic survival assays. The results indicate that AuRad nanoplatform can act as potential theranostic agent in radiation therapy.Entities:
Keywords: Gold nanoparticles; PEGylation; clonogenic assay; multifunctional nanoparticles; radiation therapy
Year: 2013 PMID: 24392307 PMCID: PMC3877840 DOI: 10.3978/j.issn.2218-676X.2013.07.02
Source DB: PubMed Journal: Transl Cancer Res ISSN: 2218-676X Impact factor: 1.241